Incivek Hepatitis C Treatment Receives More Severe Warning Label
The Food and Drug Administration has grown concerned that patients aren’t taken warnings about a certain Hepatitis C treatment seriously enough. Because of that, they have issued a more severe warning about the issue which has already led some patients to experience fatal side effects. The drug in question is known as Incivek, a Hepatitis… read more
FDA Educates Consumers About Osteoporosis Drug Risks, Rewards
The Food and Drug Administration is working hard to educate consumers about the risks and benefits of drugs meant to treat osteoporosis. The drugs in question are part of a classification known as bisphosphonates. A variety of medications fall into this category, including Fosamax, Atelvia, Boniva, and Actonel.150 million prescriptions of these and another generic… read more
FDA Requires New Labels on Popular Hepatitis C Treatment
A label change being issued by the Food and Drug Administration could hurt sales of a widely used Hepatitis C treatment. The drug whose label will need to be changed is called Victrelis, which the FDA approved last May. It is produced by Merck & Company. New findings have shown that Victrelis could prevent various… read more
FDA Issues Warning About Counterfeit Avastin
The Food and Drug Administration is doing its part to warn consumers of a counterfeit drug that made its way to the United States. A batch of counterfeit drugs purporting to be a popular cancer combating drug called Avastin has arrived in the US, and the FDA is worried about the drug making its way… read more
Study Suggests Some Epileptic Drugs May Cause Birth Defects
RxFilter, a data aggregation and refinement process company, has suggested that two epilepsy drugs defined by the FDA as having “no known human risk” may actually be dangerous to a human fetus, according to news sources. If the evidence is conclusive, it may prompt the Food and Drug Administration to reclassify the drug from a… read more